Back

Surfactant proteins changes after acute hemodynamic improvement in patients with advanced chronic heart failure treated with levosimendan

28 May 2018 (15:45 - 15:50)
Organised by:
Congress Presentation Part of: Moderated Poster session 5 - Advanced heart failure Biomarkers HFA Premium Access Heart Failure 2018

About the speaker

Photo
Doctor Massimo Mapelli

Monzino Cardiology Centre, Milan (Italy)

6 More presentations in this session

Presentation thumbnail
Stanford integrated psychosocial assessment for transplantation scores track with intermacs profile and predict readmissions in patients undergoing left ventricular assist device implantation
Doctor M. Cagliostro (New York, US)
Abstract Slides
Presentation thumbnail
What happened to patients being listed for Heart Transplantation who did not arrive to Transplantation? Reasons for coming out of the waiting list and long term follow-up
Doctor M. Castel Lavilla (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction
Professor D. Kaye (Melbourne, AU)
Abstract
Presentation thumbnail
Prognosis of patients with cardiac amyloidosis referred in the French national referral Centre for Cardiac Amyloidosis
Doctor D. Bodez (Saint Denis, FR)
Abstract
Presentation thumbnail
Angiotensin based biomarkers predict outcome in HFpEF-patients
Doctor C. Binder (Vienna, AT)
Abstract

Access the full session

Session thumbnail
Moderated Poster session 5 - Advanced heart failure

The Event

Event poster

Heart Failure 2018

28 May 2018 15:45 CET
You may be interested in
thumbnail
Congress Presentation
Levosimendan in acute heart failure: a tertiary center experience
29 June 2021
thumbnail
Congress Presentation
Prognostic value of alveolar surfactant type-B in acute heart failure: a long-term comparative analysis vs NT-proBNP
30 August 2024
thumbnail
Congress Session
From genetic signatures to clinical implications
18 May 2025
thumbnail
Congress Presentation
Intermittent levosimendan infusions for advanced heart failure: a systematic review and meta-analysis of randomized controlled trials.
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources